3.56
price up icon8.87%   0.29
after-market Dopo l'orario di chiusura: 2.75 -0.81 -22.75%
loading
Precedente Chiudi:
$3.27
Aprire:
$3.27
Volume 24 ore:
783.00K
Relative Volume:
1.01
Capitalizzazione di mercato:
$198.12M
Reddito:
$69.23M
Utile/perdita netta:
$-33.10M
Rapporto P/E:
-3.0169
EPS:
-1.18
Flusso di cassa netto:
$-39.26M
1 W Prestazione:
+4.40%
1M Prestazione:
+126.75%
6M Prestazione:
+97.78%
1 anno Prestazione:
+1.14%
Intervallo 1D:
Value
$3.2201
$3.65
Intervallo di 1 settimana:
Value
$2.88
$3.65
Portata 52W:
Value
$0.52
$5.0699

Neuronetics Inc Stock (STIM) Company Profile

Name
Nome
Neuronetics Inc
Name
Telefono
877-600-7555
Name
Indirizzo
3222 PHOENIXVILLE PIKE, MALVERN, PA
Name
Dipendente
201
Name
Cinguettio
@tmstherapy
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
STIM's Discussions on Twitter

Confronta STIM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
STIM
Neuronetics Inc
3.56 198.12M 69.23M -33.10M -39.26M -1.18
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
572.71 219.06B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
210.01 151.02B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
147.64 42.12B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
209.96 38.11B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
460.56 37.71B 3.84B 866.24M 792.60M 10.37

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-13 Downgrade William Blair Outperform → Mkt Perform
2021-10-13 Downgrade BTIG Research Buy → Neutral
2021-10-13 Downgrade William Blair Outperform → Mkt Perform
2021-01-22 Aggiornamento William Blair Mkt Perform → Outperform
2020-02-06 Iniziato BTIG Research Buy
2018-07-24 Iniziato Canaccord Genuity Buy
Mostra tutto

Neuronetics Inc Borsa (STIM) Ultime notizie

pulisher
Feb 06, 2025

Neuronetics announces public stock offering By Investing.com - Investing.com South Africa

Feb 06, 2025
pulisher
Feb 06, 2025

Neuronetics announces public stock offering - Investing.com India

Feb 06, 2025
pulisher
Feb 06, 2025

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock - The Manila Times

Feb 06, 2025
pulisher
Feb 06, 2025

Major Stock Offering Alert: Neuronetics Takes Bold Step to Raise Capital Through Public Markets - StockTitan

Feb 06, 2025
pulisher
Feb 06, 2025

Are Smart Investors Making the Right Decision? Neuronetics Inc (STIM) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Medical Transcranial Magnetic Stimulator Market Generated - openPR

Feb 06, 2025
pulisher
Feb 05, 2025

Neuronetics Inc (STIM)’s stock chart: A technical perspective - US Post News

Feb 05, 2025
pulisher
Feb 05, 2025

Market Momentum Report: Neuronetics Inc (STIM)’s Positive Close at 3.45 - The Dwinnex

Feb 05, 2025
pulisher
Feb 04, 2025

Neuronetics Inc (STIM) rating downgrades by William Blair - Knox Daily

Feb 04, 2025
pulisher
Feb 03, 2025

Unlocking the Healthcare Boom: Why Neuronetics is a Game-Changer for Investors - Jomfruland.net

Feb 03, 2025
pulisher
Feb 03, 2025

Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 - Insider Monkey

Feb 03, 2025
pulisher
Feb 02, 2025

Short Interest in Neuronetics, Inc. (NASDAQ:STIM) Drops By 35.8% - MarketBeat

Feb 02, 2025
pulisher
Jan 29, 2025

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression - The Manila Times

Jan 29, 2025
pulisher
Jan 29, 2025

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression -January 29, 2025 at 08:32 am EST - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression -January 29, 2025 at 08:31 am EST - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

Neuronetics, Inc. Unveils Two Significant Publications on TMS Therapy for Depression - Marketscreener.com

Jan 29, 2025
pulisher
Jan 29, 2025

Neuronetics (NASDAQ:STIM) shareholders are up 34% this past week, but still in the red over the last five years - Yahoo Finance

Jan 29, 2025
pulisher
Jan 29, 2025

Breakthrough Depression Treatment Achieves Universal Success Rate, Research Confirms - StockTitan

Jan 29, 2025
pulisher
Jan 24, 2025

Neuronetics Reports 2024 Revenue Growth, Reveals Optimistic 2025 Guidance - MSN

Jan 24, 2025
pulisher
Jan 20, 2025

Neuronetics (NASDAQ: STIM) Files 8-K with Preliminary Financial Information - Defense World

Jan 20, 2025
pulisher
Jan 14, 2025

Neuronetics, Inc. Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024 - Marketscreener.com

Jan 14, 2025
pulisher
Jan 14, 2025

Neuronetics, Inc. (NASDAQ:STIM) Sees Significant Drop in Short Interest - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Neuronetics forecasts revenue growth and cost savings post-acquisition - Investing.com India

Jan 13, 2025
pulisher
Jan 13, 2025

Neuronetics Projects Growth Following Greenbrook Acquisition - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

Neuronetics Provides Business Update and Issues 2025 Guidance - The Manila Times

Jan 13, 2025
pulisher
Jan 13, 2025

Neuronetics Projects Strong 2025 Growth, Expands NeuroStar Depression Treatment to Teens - StockTitan

Jan 13, 2025
pulisher
Jan 11, 2025

Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 43% Yet They're Still Not Telling The Full Story - Simply Wall St

Jan 11, 2025
pulisher
Jan 08, 2025

Transcranial Magnetic Stimulator Market Growth in Future Scope - openPR

Jan 08, 2025
pulisher
Jan 07, 2025

Transcranial Magnetic Stimulator Market Report, Size, Trends, - openPR

Jan 07, 2025
pulisher
Jan 07, 2025

Critical Survey: Neuronetics (NASDAQ:STIM) vs. Tenon Medical (NASDAQ:TNON) - Defense World

Jan 07, 2025
pulisher
Jan 03, 2025

Neuronetics Awards Stock Units to New Employee Bill Leonard - MSN

Jan 03, 2025
pulisher
Jan 02, 2025

Neuronetics (NASDAQ:STIM) Is Making Moderate Use Of Debt - Simply Wall St

Jan 02, 2025
pulisher
Dec 26, 2024

HighTower Advisors LLC Increases Stock Holdings in Neuronetics, Inc. (NASDAQ:STIM) - Defense World

Dec 26, 2024
pulisher
Dec 23, 2024

Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com

Dec 23, 2024
pulisher
Dec 20, 2024

Neuronetics Revamps TrakStar System, Streamlining Patient Data Management - MSN

Dec 20, 2024
pulisher
Dec 19, 2024

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Dec 19, 2024
pulisher
Dec 18, 2024

Neuronetics Grants Strategic 50,000 PRSU Inducement Award to Key New Employee - StockTitan

Dec 18, 2024
pulisher
Dec 17, 2024

Neuronetics' SWOT analysis: merger impact on neurohealth stock By Investing.com - Investing.com Australia

Dec 17, 2024
pulisher
Dec 16, 2024

Neuronetics Unveils Strategic Performance-Based Stock Awards Targeting Cash Flow Breakeven by 2025 - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Neuronetics' SWOT analysis: merger impact on neurohealth stock - Investing.com

Dec 16, 2024
pulisher
Dec 11, 2024

Neuronetics, Greenbrook TMS close transaction - Medical Buyer

Dec 11, 2024
pulisher
Dec 10, 2024

Neuronetics Expands with Greenbrook TMS Acquisition - TipRanks

Dec 10, 2024
pulisher
Dec 10, 2024

Madryn Provides Update on Holdings of Greenbrook TMS Inc. - The Manila Times

Dec 10, 2024
pulisher
Dec 10, 2024

Neuronetics and Greenbrook TMS Announce Closing of Transaction - The Manila Times

Dec 10, 2024
pulisher
Dec 07, 2024

Reviewing Stryker (NYSE:SYK) & Neuronetics (NASDAQ:STIM) - Defense World

Dec 07, 2024
pulisher
Dec 05, 2024

Neuronetics' SWOT analysis: merger, market challenges shape TMS stock outlook - Investing.com Nigeria

Dec 05, 2024
pulisher
Dec 01, 2024

Neuronetics (STU:NRC) 3-Year EPS without NRI Growth Rate : 9.40% (As of Sep. 2024) - GuruFocus.com

Dec 01, 2024

Neuronetics Inc Azioni (STIM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$122.80
price down icon 1.51%
diagnostics_research LH
$247.74
price down icon 0.90%
$175.14
price down icon 1.05%
diagnostics_research WAT
$410.95
price down icon 0.76%
diagnostics_research MTD
$1,357.26
price down icon 0.46%
$460.56
price down icon 1.71%
Capitalizzazione:     |  Volume (24 ore):